Join us for an enlightening virtual session featuring the co-founder of iGenomeDx, a San Antonio–based molecular diagnostics laboratory that’s transforming clinical decision-making in Texas and beyond.
Wednesday, July 30, 2025
2:00 – 3:30 PM CT
Featuring
Niti Vanee, PhD
iGenomeDx, Co-Founder & CEO
Established in 2016 by genetic research scientists, iGenomeDx delivers fast, reliable, and actionable lab results—designed to support healthcare providers and improve patient outcomes. Fueled by advanced tools such as PCR and LC–MS, iGenomeDx offers a comprehensive suite of diagnostic services including:
- Pharmacogenomics (PGx) to guide medication choices
- PCR-based Infectious disease panels for respiratory, urinary tract & more
- Drug testing through urine and oral toxicology
With multiple certifications and national outreach, iGenomeDx combines innovation with integrity. Their mission: support faster diagnoses and smarter treatments—reducing hospital stays and cutting overall healthcare costs. Notably, the company is certified Women owned, Minority Owned Small business, and was recognized as a 2022 Minority-Owned Small Business of the Year by the San Antonio Chapter of Small Business Administration.
In this exclusive online session, she will share:
- Personalized Medicine and PGx implementation in a health system.
- Strategic insights on compliance, operations, and healthcare economics.
- Future outlook on where precession diagnostics is heading.
Mark your calendar and register now to hear how iGenomeDx is enhancing care through science, speed, and service—and what it means for healthcare in our community.